Labels on packs is as difficult to read as ‘conditions apply’.
In the case of Food products it seems to me that the manufacturer’s aim is to comply with the regulation and at the same time make sure that you do not read what is written.
I came across information that tells you understand the Labels in Food Products.( if you can read them!)
Story:
Did you know that when you pick up a product promoted as trans fat free, you may still be ingesting a significant amount of this potentially harmful substance? An article by Eric Brandt reveals that misleading labeling practices can result in medically significant intake of harmful trans fat, despite what you read on Food and Drug Administration (FDA) approved labels.
Indeed, consumers’ inability to identify high-risk foods may cause individuals to exceed the daily recommended value of 1.11 grams of trans fat from processed foods and lead to adverse long-term health side effects.Ingestion of trans fat is a known public health concern. Top national health organizations, such as the U.S. Department of Health and Human Services and American Heart Association, suggest trans fats be ingested in limited quantities. However, current FDA labeling protocol and policy prevents the public from accessing the true amount of trans fat contained in their food products…
(SimonQ, CC BY-NC-ND 2.0) Acetaminophen kills hundreds of Americans every year, sending thousands to the emergency room with at least 2,600 hospital admissions.
Presently, the drug manufacturer is defending itself in federal court from at least 85 different lawsuits from consumers claiming harm and from surviving family members claiming wrongful death, with heartrending anecdotes about the deceased. During the past decade, hundreds of Americans have died after unintentional overdoses of the country’s most popular pain reliever.
Nearly 500 Americans die yearly from acetaminophen overdoses, with 2,600 hospitalizations and some 56,000 emergency room visits, according to a 2004 study from the University of Texas. The drug is also implicated in nearly half of all cases of liver damage, researchers say. At the same time,the Tylenol brand makes more than $1 billion in revenue every year, aside from competitors.
Although the U.S. Food and Drug Administration (FDA) refers to acetaminophen overdose as a “persistent, important public health problem,” regulatory oversight of the drug — safe for adults, children, and infants in the right doses — has been criticized by some as too lax, compared to other developed countries from Europe to Asia. U.S. regulators ruled in 2009 to require a label warning of “severe liver damage” after convening an expert panel in 1977 — 32 years later.
Despite warnings from campaigners, the online shop is selling salvia and describing it as ‘more powerful than LSD’.
Nitrous oxide and poppers, which can be similarly lethal, are on sale as well. Maryon Stewart, whose daughter Hester died after taking the drug GBL, wrote to Amazon last month, asking it to withdraw the products along with drug pipes, bongs and scales….
She has had no response and last night said: ‘It is utterly irresponsible that Amazon is selling this stuff and tantamount to an endorsement.
Endorsement for withdrawn Drug.
‘Amazon is a trusted brand and if it is selling something, it is likely to mislead young people into believing it’s safe.
‘We all know these products are not safe and people taking them are playing Russian roulette with their lives and mental wellbeing.’ EBay does not allow legal highs or drugs equipment to be sold through its site because it says they may ‘cause harm’.
It boasts of providing ‘the purest extracts at the best prices in the UK’ and cites Press articles describing the psychoactive herb as ‘more powerful than LSD, and legal’.
It states: ‘Salvia continues to be used by Mazatec shamans in its native Oaxaca for its spiritual effects, which last for five minutes and offer the shamans deep psychological effects.’
I had posted articles on how Ranbaxy had fallen short of FDA Standards and Johnson & Johnson Product Licence was canceled in India for the presence of Carcinogen.
Ranbaxy
However I have received emails and in the form of comments to that post(Johnson and Johnson) expressing a desire to continue with their products on the ground that they are being used for quite a number of years and would I mail more information on the subject.
I hold no grudge against Pharma Companies, so long as what they produce is of acceptable standard and are not exorbitantly Priced.
A suspicion and a report that the Products are suspect or have failed tests is sufficient for me to inform people to stop using the products for we are dealing with Lives.
One should know that FDA of US also has corrupt Officials(Please read The Final Diagnosis of Arthur Hailey) and when FDA issues warning it must be understood that they are being issued despite Money and Political Pressure.
Yet the desire to continue with their products persists, such is the power of Television Advertisements!
Now I find Johnson & Johnson coming out with very catchy advertisements in TV placing the Products as a family’s Trusted product for the same Product that was banned.
“We understand their concerns and are diligently working with them to resolve the issue,” Peggy Ballman, a J&J spokeswoman, said in a statement, adding that there were no consumer complaints or adverse events reported due to its use of the process. An investigation by the Maharashtra Food and Drug Administration revealed that J&J, at its plant in Mulund, had used ethylene oxide – a substance used to produce industrial chemicals and to sterilize medical equipment – to kill bacteria in its baby powder and had not conducted mandatory tests to make sure there were no remaining traces in the powder. According to the U.S. Department of Labor, acute exposure to ethylene oxide can cause lung damage, nausea, vomiting and cancer.
As for as Ranbaxy is concerned, it has been served with Notices, not once, but Five Notices in Five Years!
The following are examples of the observations that support our conclusion that Ranbaxy submitted untrue statements of material fact in drug applications filed with the Agency: 1. Ranbaxy submitted stability information in numerous approved and pending applications that contain untrue statements of material fact, because Ranbaxy failed to include critical information about the storage and testing of the product. During a February 2006 inspection of the Paonta Sahib manufacturing facility, FDA found that hundreds of stability samples, many of which were being used for room temperature or accelerated stability studies, were being stored in refrigerators at approximately between the time they were removed from their stability chamber and the time they were tested. Among other things, FDA investigators found that the sample logbooks did not identify the samples that were being held in the refrigerators, their storage duration in the refrigerators, and the justification for this storage. FDA issued a June 15, 2006 warning letter to Ranbaxy based on its findings during this inspection, including the circumstances of these refrigerated stability samples.
You must be logged in to post a comment.